COVID-19 and immune checkpoint inhibitors

被引：3
作者：
Ahmed, M. S. [1 ,2 ,3 ]
Brehme, H. [4 ]
Friedrich, S. [4 ]
Reinhardt, L. [1 ,2 ,3 ]
Blum, S. [5 ]
Beissert, S. [1 ,2 ,3 ]
Meier, F. [1 ,2 ,3 ]
机构：
[1] Univ Canc Ctr, Skin Canc Ctr, Dresden, Germany
[2] Natl Ctr Tumor Dis, Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Dermatol, Dresden, Germany
[4] Tech Univ Dresden, Acad Teaching Hosp, Hosp Dresden Friedrichstadt, Dept Anesthesiol & Intens Care,Emergency Med & Pa, Dresden, Germany
[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst & Polyclin Diagnost & Intervent Radiol, Dresden, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 05期
关键词：
D O I：
10.1111/jdv.17172
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E312 / E314
页数：3
相关论文
共 10 条
  • [1] Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients
    Bersanelli, Melissa
    Scala, Stefania
    Affanni, Paola
    Veronesi, Licia
    Colucci, Maria Eugenia
    Banna, Giuseppe Luigi
    Cortellini, Alessio
    Liotta, Francesco
    [J]. IMMUNOTHERAPY, 2020, 12 (02) : 105 - 110
  • [2] Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
    Fillmore, Nathanael R.
    La, Jennifer
    Szalat, Raphael E.
    Tuck, David P.
    Vinh Nguyen
    Yildirim, Cenk
    Do, Nhan, V
    Brophy, Mary T.
    Munshi, Nikhil C.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (06): : 691 - 698
  • [3] Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
    Gupta, Shruti
    Wang, Wei
    Hayek, Salim S.
    Chan, Lili
    Mathews, Kusum S.
    Melamed, Michal L.
    Brenner, Samantha K.
    Leonberg-Yoo, Amanda
    Schenck, Edward J.
    Radbel, Jared
    Reiser, Jochen
    Bansal, Anip
    Srivastava, Anand
    Zhou, Yan
    Finkel, Diana
    Green, Adam
    Mallappallil, Mary
    Faugno, Anthony J.
    Zhang, Jingjing
    Velez, Juan Carlos Q.
    Shaefi, Shahzad
    Parikh, Chirag R.
    Charytan, David M.
    Athavale, Ambarish M.
    Friedman, Allon N.
    Redfern, Roberta E.
    Short, Samuel A. P.
    Correa, Simon
    Pokharel, Kapil K.
    Admon, Andrew J.
    Donnelly, John P.
    Gershengorn, Hayley B.
    Douin, David J.
    Semler, Matthew W.
    Hernan, Miguel A.
    Leaf, David E.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 41 - 51
  • [4] Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
    Hermine, Olivier
    Mariette, Xavier
    Tharaux, Pierre-Louis
    Resche-Rigon, Matthieu
    Porcher, Raphael
    Ravaud, Philippe
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 32 - 40
  • [5] Cytokine release syndrome in severe COVID-19
    Moore, John B.
    June, Carl H.
    [J]. SCIENCE, 2020, 368 (6490) : 473 - 474
  • [6] Determinants of COVID-19 disease severity in patients with cancer
    Robilotti, Elizabeth V.
    Babady, N. Esther
    Mead, Peter A.
    Rolling, Thierry
    Perez-Johnston, Rocio
    Bernardes, Marilia
    Bogler, Yael
    Caldararo, Mario
    Figueroa, Cesar J.
    Glickman, Michael S.
    Joanow, Alexa
    Kaltsas, Anna
    Lee, Yeon Joo
    Lucca, Anabella
    Mariano, Amanda
    Morjaria, Sejal
    Nawar, Tamara
    Papanicolaou, Genovefa A.
    Predmore, Jacqueline
    Redelman-Sidi, Gil
    Schmidt, Elizabeth
    Seo, Susan K.
    Sepkowitz, Kent
    Shah, Monika K.
    Wolchok, Jedd D.
    Hohl, Tobias M.
    Taur, Ying
    Kamboj, Mini
    [J]. NATURE MEDICINE, 2020, 26 (08) : 1218 - +
  • [7] Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
    Stone, John H.
    Frigault, Matthew J.
    Serling-Boyd, Naomi J.
    Fernandes, Ana D.
    Harvey, Liam
    Foulkes, Andrea S.
    Horick, Nora K.
    Healy, Brian C.
    Shah, Ruta
    Bensaci, Ana Maria
    Woolley, Ann E.
    Nikiforow, Sarah
    Lin, Nina
    Sagar, Manish
    Schrager, Harry
    Huckins, David S.
    Axelrod, Matthew
    Pincus, Michael D.
    Fleisher, Jorge
    Sacks, Chana A.
    Dougan, Michael
    North, Crystal M.
    Halvorsen, Yuan-Di
    Thurber, Tara K.
    Dagher, Zeina
    Scherer, Allison
    Wallwork, Rachel S.
    Kim, Arthur Y.
    Schoenfeld, Sara
    Sen, Pritha
    Neilan, Tomas G.
    Perugino, Cory A.
    Unizony, Sebastian H.
    Collier, Deborah S.
    Matza, Mark A.
    Yinh, Janeth M.
    Bowman, Kathryn A.
    Meyerowitz, Eric
    Zafar, Amna
    Drobni, Zsofia D.
    Bolster, Marcy B.
    Kohler, Minna
    D'Silva, Kristin M.
    Dau, Jonathan
    Lockwood, Megan M.
    Cubbison, Caroline
    Weber, Brittany N.
    Mansour, Michael K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24) : 2333 - 2344
  • [8] Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
    Sud, Amit
    Torr, Bethany
    Jones, Michael E.
    Broggio, John
    Scott, Stephen
    Loveday, Chey
    Garrett, Alice
    Gronthoud, Firza
    Nicol, David L.
    Jhanji, Shaman
    Boyce, Stephen A.
    Williams, Matthew
    Riboli, Elio
    Muller, David C.
    Kipps, Emma
    Larkin, James
    Navani, Neal
    Swanton, Charles
    Lyratzopoulos, Georgios
    McFerran, Ethna
    Lawler, Mark
    Houlston, Richard
    Turnbull, Clare
    [J]. LANCET ONCOLOGY, 2020, 21 (08) : 1035 - 1044
  • [9] COVID-19 and immune checkpoint inhibitors: initial considerations
    Sullivan, Ryan J.
    Johnson, Douglas B.
    Rini, Brian, I
    Neilan, Tomas G.
    Lovly, Christine M.
    Moslehi, Javid J.
    Reynolds, Kerry L.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [10] WHO, 2020, QANDA DEXAMETHASONE
1